Concomitant Eruptive Squamous Atypia and Bullous Drug Eruption Associated with Pembrolizumab. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 8, n. 6, p. 2006–2010, 2024. DOI: 10.25251/skin.8.6.17. Disponível em: https://skin.dermsquared.com/skin/article/view/2837. Acesso em: 19 may. 2025.